202 related articles for article (PubMed ID: 29453990)
1. ATP-activated P2X7 receptor in the pathophysiology of mood disorders and as an emerging target for the development of novel antidepressant therapeutics.
Wei L; Syed Mortadza SA; Yan J; Zhang L; Wang L; Yin Y; Li C; Chalon S; Emond P; Belzung C; Li D; Lu C; Roger S; Jiang LH
Neurosci Biobehav Rev; 2018 Apr; 87():192-205. PubMed ID: 29453990
[TBL] [Abstract][Full Text] [Related]
2. Leveraging the ATP-P2X7 receptor signalling axis to alleviate traumatic CNS damage and related complications.
Yin Y; Wei L; Caseley EA; Lopez-Charcas O; Wei Y; Li D; Muench SP; Roger S; Wang L; Jiang LH
Med Res Rev; 2023 Sep; 43(5):1346-1373. PubMed ID: 36924449
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of the P2X7-NLRP3-IL1β pathway in mood disorders.
Bhattacharya A; Jones DNC
Psychoneuroendocrinology; 2018 Dec; 98():95-100. PubMed ID: 30121550
[TBL] [Abstract][Full Text] [Related]
4. The P2X7 receptor in mood disorders: Emerging target in immunopsychiatry, from bench to bedside.
von Mücke-Heim IA; Deussing JM
Neuropharmacology; 2023 Feb; 224():109366. PubMed ID: 36470368
[TBL] [Abstract][Full Text] [Related]
5. The first CNS-active carborane: A novel P2X7 receptor antagonist with antidepressant activity.
Wilkinson SM; Gunosewoyo H; Barron ML; Boucher A; McDonnell M; Turner P; Morrison DE; Bennett MR; McGregor IS; Rendina LM; Kassiou M
ACS Chem Neurosci; 2014 May; 5(5):335-9. PubMed ID: 24689484
[TBL] [Abstract][Full Text] [Related]
6. P2X7 receptor: a critical regulator and potential target for breast cancer.
Zhu X; Li Q; Song W; Peng X; Zhao R
J Mol Med (Berl); 2021 Mar; 99(3):349-358. PubMed ID: 33486566
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in the Development of Antidepressants Targeting the Purinergic P2X7 Receptor.
Lee S; Ha H; Jang J; Byun Y
Curr Med Chem; 2023; 30(2):164-177. PubMed ID: 35770396
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.
Bhattacharya A; Wang Q; Ao H; Shoblock JR; Lord B; Aluisio L; Fraser I; Nepomuceno D; Neff RA; Welty N; Lovenberg TW; Bonaventure P; Wickenden AD; Letavic MA
Br J Pharmacol; 2013 Oct; 170(3):624-40. PubMed ID: 23889535
[TBL] [Abstract][Full Text] [Related]
9. The role and pharmacological properties of the P2X7 receptor in neuropathic pain.
Zhang WJ; Zhu ZM; Liu ZX
Brain Res Bull; 2020 Feb; 155():19-28. PubMed ID: 31778766
[TBL] [Abstract][Full Text] [Related]
10. The microglial ATP-gated ion channel P2X7 as a CNS drug target.
Bhattacharya A; Biber K
Glia; 2016 Oct; 64(10):1772-87. PubMed ID: 27219534
[TBL] [Abstract][Full Text] [Related]
11. The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor.
Hempel C; Nörenberg W; Sobottka H; Urban N; Nicke A; Fischer W; Schaefer M
Neuropharmacology; 2013 Dec; 75():365-79. PubMed ID: 23954492
[TBL] [Abstract][Full Text] [Related]
12. Purinergic P2X7 receptor as a potential therapeutic target in depression.
Qi W; Jin X; Guan W
Biochem Pharmacol; 2024 Jan; 219():115959. PubMed ID: 38052270
[TBL] [Abstract][Full Text] [Related]
13. P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone.
Messemer N; Kunert C; Grohmann M; Sobottka H; Nieber K; Zimmermann H; Franke H; Nörenberg W; Straub I; Schaefer M; Riedel T; Illes P; Rubini P
Neuropharmacology; 2013 Oct; 73():122-37. PubMed ID: 23727220
[TBL] [Abstract][Full Text] [Related]
14. P2X7 receptor antagonists for the treatment of systemic inflammatory disorders.
Gelin CF; Bhattacharya A; Letavic MA
Prog Med Chem; 2020; 59():63-99. PubMed ID: 32362329
[TBL] [Abstract][Full Text] [Related]
15. P2X7-dependent, but differentially regulated release of IL-6, CCL2, and TNF-α in cultured mouse microglia.
Shieh CH; Heinrich A; Serchov T; van Calker D; Biber K
Glia; 2014 Apr; 62(4):592-607. PubMed ID: 24470356
[TBL] [Abstract][Full Text] [Related]
16. ATP-induced currents carried through P2X7 receptor in rat myometrial cells.
Miyoshi H; Yamaoka K; Urabe S; Kudo Y
Reprod Sci; 2012 Dec; 19(12):1285-91. PubMed ID: 22814097
[TBL] [Abstract][Full Text] [Related]
17. Mechanical stress-induced interleukin-1beta expression through adenosine triphosphate/P2X7 receptor activation in human periodontal ligament cells.
Kanjanamekanant K; Luckprom P; Pavasant P
J Periodontal Res; 2013 Apr; 48(2):169-76. PubMed ID: 22881405
[TBL] [Abstract][Full Text] [Related]
18. P2X7 receptor in cardiovascular disease: The heart side.
Guerra Martinez C
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):513-526. PubMed ID: 30834550
[TBL] [Abstract][Full Text] [Related]
19. P2X receptors: Insights from the study of the domestic dog.
Sluyter R; Sophocleous RA; Stokes L
Neuropharmacology; 2023 Feb; 224():109358. PubMed ID: 36464207
[TBL] [Abstract][Full Text] [Related]
20. The evolution of P2X7 antagonists with a focus on CNS indications.
Rech JC; Bhattacharya A; Letavic MA; Savall BM
Bioorg Med Chem Lett; 2016 Aug; 26(16):3838-45. PubMed ID: 27426304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
